1) 12-Second Assessment: Delivers rapid cardiovascular risk evaluation in just 12 seconds. 2) Non-Invasive Technology: Measures Advanced Glycation End Products (AGEs) without blood draws, offering a fast and painless process. 3) Comprehensive Health Insights: Reflects vascular damage, predicts cardiovascular complication risks, and evaluates the likelihood of diabetes, kidney failure, and metabolic syndrome. 4) Smart & Portable Design: Features one-handed operation and instant Bluetooth report transmission. Highly portable and cost-effective for high patient throughput across diverse healthcare settings